| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442414 | European Journal of Cancer | 2015 | 8 Pages |
Abstract
ETS is a good prognostic factor but an inappropriate surrogate for predicting outcome in CRC patients. These findings support ETS as prognostic tool in ascertaining earlier non-responders; however, its role as a surrogate end-point deserves further evaluation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Fausto Petrelli, Filippo Pietrantonio, Chiara Cremolini, Maria Di Bartolomeo, Andrea Coinu, Veronica Lonati, Filippo de Braud, Sandro Barni,